Question 1

What is Gossamer Bio?

Accepted Answer

Gossamer Bio is a Company.

Question 2

How often does Gossamer Bio appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 121 articles.

Question 3

When was Gossamer Bio first tracked by NewsDesk?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Gossamer Bio last mentioned in news?

Accepted Answer

Last active on May 28, 2026.

Question 5

What is Gossamer Bio's current news sentiment?

Accepted Answer

Aggregate sentiment score: -85 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Gossamer Bio in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Gossamer Bio?

Accepted Answer

Gossamer Bio PROSERA Study Failure Lawsuits (Apr 01, 2026, 103 articles).

Question 8

How did the "Gossamer Bio PROSERA Study Failure Lawsuits" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is the defendant in multiple class action lawsuits following the failure of its Phase 3 PROSERA study, which led to an 80% drop in its stock price and potential delisting from Nasdaq-100. The lawsuits allege securities fraud due to undisclosed issues with the trial design.

Question 9

How did the "Gossamer Bio Securities Fraud Lawsuit" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is facing a class action lawsuit for allegedly making false and misleading statements regarding its Phase 3 PROSERA study, which has caused investors to suffer damages.

Question 10

How did the "Gossamer Bio Faces Securities Lawsuit" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is facing a securities class action lawsuit after its Phase 3 PROSERA study failed to meet its primary endpoint, causing an 80% drop in its stock price and potential delisting from Nasdaq-100. The lawsuit alleges that Gossamer Bio misled investors about the trial design.

Question 11

How did the "Gossamer Bio Securities Class Action" event impact Gossamer Bio?

Accepted Answer

Gossamer Bio is facing a securities class action lawsuit due to alleged misleading statements regarding its Phase 3 PROSERA study, which led to an over 80% drop in its stock price.

Question 12

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.